| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 |
|---|---|---|---|---|---|---|
Revenue | ||||||
- | 86 | - | - | - | - | - |
Revenue | ||||||
- | - | - | 7 | - | - | - |
Revenue | ||||||
- | - | - | - | 278 | 810 | 943 |
Operating expenses: | ||||||
Research and development | ||||||
20,400 | 27,200 | 22,800 | 16,784 | 7,445 | 2,401 | 1,134 |
General and administrative | ||||||
13,935 | 13,238 | 10,016 | 6,430 | 5,364 | 4,076 | 444 |
Total operating expenses | ||||||
34,319 | 40,483 | 32,823 | 23,214 | 12,810 | 6,477 | 1,578 |
Loss from operations | ||||||
-34,319 | -40,397 | -32,823 | -23,207 | -12,531 | -5,667 | -634 |
Other income (expense): | ||||||
Interest income | ||||||
1,522 | 961 | 519 | 80 | 7 | - | - |
Interest income | ||||||
- | - | - | - | - | -1 | -2 |
Foreign exchange loss | ||||||
-145 | -474 | 291 | -189 | - | - | - |
Loss on disposal of equipment | ||||||
- | - | - | -99 | - | - | - |
Total other income | ||||||
1,376 | 486 | 810 | -208 | 7 | -1 | - |
Loss before income taxes | ||||||
- | - | - | -23,416 | -12,523 | -5,669 | - |
Loss before income taxes | ||||||
- | - | - | - | - | - | -636 |
Income tax benefit | ||||||
- | - | - | -27 | 27 | - | - |
Net loss | ||||||
- | - | - | - | - | -5,669 | -636 |
Accretion of redeemable convertible preferred stock | ||||||
- | - | - | - | - | 87 | 161 |
Net loss | ||||||
-32,943 | -39,911 | -32,012 | -23,388 | -12,551 | -5,757 | -798 |
Net loss per share basic and diluted | ||||||
-1.50 | -2.61 | -2.48 | -2.58 | -2.82 | -6.44 | -1.63 |
Basic and diluted weighted average shares outstanding | ||||||
22,000 | 15,308 | 12,914 | 9,070 | 4,457 | 894 | 490 |